search
Back to results

Melatonin and Sleep in Preventing Delirium in the Hospital (MELO)

Primary Purpose

Delirium

Status
Completed
Phase
Phase 1
Locations
United States
Study Type
Interventional
Intervention
Melatonin
Placebo
Sponsored by
Scripps Health
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional prevention trial for Delirium focused on measuring Delirium, Melatonin

Eligibility Criteria

65 Years - 100 Years (Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • 65-100 years old
  • Admitted to Scripps Green Hospital
  • Admitted to an Internal Medicine or Medicine Consult Service
  • Expected to have a hospital stay of greater than or equal to 48 hours (patients admitted to "inpatient," not "observation," under Medicare guidelines)

Exclusion Criteria:

  • Cirrhosis of any etiology
  • Admitted for alcohol withdrawal
  • Currently taking a 1st or 2nd generation anti-psychotic
  • Active delirium (i.e., delirium prior to 1st dose of melatonin)
  • Diagnosis of encephalitis
  • History of seizure

Sites / Locations

  • Scripps Green Hospital

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Placebo Comparator

Arm Label

Melatonin Group

Placebo Group

Arm Description

Patients in this group will receive melatonin 3mg orally at 9pm.

Patient in this group will receive a matching placebo pill orally at 9pm.

Outcomes

Primary Outcome Measures

Delirium as measured by CAM Assessment
Primary outcome is whether patients become delirious, as measured by CAM during their hospital admission.

Secondary Outcome Measures

Objective Sleep Quality, measured by nocturnal sleep duration
Nocturnal sleep duration will be measured by wireless actigraphy.
Objective sleep quality, measured by number of nighttime wakenings
We will measure the number of nighttime wakenings using wireless actigraphy.
Objective sleep quality, measured by sleep latency
We will measure sleep latency (time to fall asleep) using wireless actigraphy.
Subjective sleep quality, measured by Richards-Campbell sleep questionnaire
Patients will be asked to fill out the Richards-Campbell sleep question, which uses a visual analog scale for 5 questions that are designed to assess a patient's perceived sleep quality.

Full Information

First Posted
October 1, 2015
Last Updated
October 3, 2017
Sponsor
Scripps Health
Collaborators
Scripps Clinic
search

1. Study Identification

Unique Protocol Identification Number
NCT02597231
Brief Title
Melatonin and Sleep in Preventing Delirium in the Hospital
Acronym
MELO
Official Title
Melatonin and Sleep in Preventing Delirium in the Hospital: A Randomized Placebo-controlled Trial
Study Type
Interventional

2. Study Status

Record Verification Date
October 2017
Overall Recruitment Status
Completed
Study Start Date
November 2015 (Actual)
Primary Completion Date
December 2016 (Actual)
Study Completion Date
December 31, 2016 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Scripps Health
Collaborators
Scripps Clinic

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
Recent data suggests that melatonin, a supplement available over the counter, may help prevent delirium in hospitalized patients. The investigators are hypothesizing that melatonin may help in delirium prevention by improving sleep quality and possibly circadian rhythm cycling in patients who are given the supplement. This pilot study involves a randomized placebo-controlled design in which participants will be randomized to receive either melatonin 3mg orally or placebo orally. Participants in both groups will be fitted with wireless actigraphy devices to obtain objective sleep quality, and will also receive a sleep questionnaire each morning to obtain subjective data on their sleep quality overnight. Delirium will be assessed by floor nurses twice daily using the Confusion Assessment Method (CAM).

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Delirium
Keywords
Delirium, Melatonin

7. Study Design

Primary Purpose
Prevention
Study Phase
Phase 1, Phase 2
Interventional Study Model
Parallel Assignment
Masking
ParticipantCare ProviderInvestigatorOutcomes Assessor
Allocation
Randomized
Enrollment
94 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Melatonin Group
Arm Type
Experimental
Arm Description
Patients in this group will receive melatonin 3mg orally at 9pm.
Arm Title
Placebo Group
Arm Type
Placebo Comparator
Arm Description
Patient in this group will receive a matching placebo pill orally at 9pm.
Intervention Type
Dietary Supplement
Intervention Name(s)
Melatonin
Intervention Description
Melatonin is the dietary supplement we are using in delirium prevention.
Intervention Type
Other
Intervention Name(s)
Placebo
Intervention Description
Patients in this group will receive a matching placebo pill.
Primary Outcome Measure Information:
Title
Delirium as measured by CAM Assessment
Description
Primary outcome is whether patients become delirious, as measured by CAM during their hospital admission.
Time Frame
Delirium assessments will be made twice daily (am and pm measurements) throughout the course of the patient's admission, or to the end of a 2 week period of enrollment - whichever comes first.
Secondary Outcome Measure Information:
Title
Objective Sleep Quality, measured by nocturnal sleep duration
Description
Nocturnal sleep duration will be measured by wireless actigraphy.
Time Frame
nightly, throughout the course of the patient's admission, or to the end of a 2 week period of enrollment - whichever comes first.
Title
Objective sleep quality, measured by number of nighttime wakenings
Description
We will measure the number of nighttime wakenings using wireless actigraphy.
Time Frame
nightly, throughout the course of the patient's admission, or to the end of a 2 week period of enrollment - whichever comes first.
Title
Objective sleep quality, measured by sleep latency
Description
We will measure sleep latency (time to fall asleep) using wireless actigraphy.
Time Frame
nightly, throughout the course of the patient's admission, or to the end of a 2 week period of enrollment - whichever comes first.
Title
Subjective sleep quality, measured by Richards-Campbell sleep questionnaire
Description
Patients will be asked to fill out the Richards-Campbell sleep question, which uses a visual analog scale for 5 questions that are designed to assess a patient's perceived sleep quality.
Time Frame
once daily, throughout the course of the patient's admission, or to the end of a 2 week period of enrollment - whichever comes first.
Other Pre-specified Outcome Measures:
Title
Mortality
Time Frame
6 month
Title
Disposition following hospitalization
Description
We want to determine if the patient is discharged to home, to a post-acute care facility, or to a new type of living facility that was different from their prior living situation.
Time Frame
1 day following hospital discharge or at the 2 week time end point of the study.
Title
Subjective sleep quality following hospital discharge.
Description
Patients will be given an insomnia questionnaire over the phone at 6 months.
Time Frame
6 months following hospital discharge

10. Eligibility

Sex
All
Minimum Age & Unit of Time
65 Years
Maximum Age & Unit of Time
100 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: 65-100 years old Admitted to Scripps Green Hospital Admitted to an Internal Medicine or Medicine Consult Service Expected to have a hospital stay of greater than or equal to 48 hours (patients admitted to "inpatient," not "observation," under Medicare guidelines) Exclusion Criteria: Cirrhosis of any etiology Admitted for alcohol withdrawal Currently taking a 1st or 2nd generation anti-psychotic Active delirium (i.e., delirium prior to 1st dose of melatonin) Diagnosis of encephalitis History of seizure
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Thomas McCarthy, MD
Organizational Affiliation
Scripps Health
Official's Role
Principal Investigator
Facility Information:
Facility Name
Scripps Green Hospital
City
La Jolla
State/Province
California
ZIP/Postal Code
92037
Country
United States

12. IPD Sharing Statement

Citations:
PubMed Identifier
33051948
Citation
Jaiswal SJ, Kang DY, Wineinger NE, Owens RL. Objectively measured sleep fragmentation is associated with incident delirium in older hospitalized patients: Analysis of data collected from an randomized controlled trial. J Sleep Res. 2021 Jun;30(3):e13205. doi: 10.1111/jsr.13205. Epub 2020 Oct 13.
Results Reference
derived
PubMed Identifier
29729237
Citation
Jaiswal SJ, McCarthy TJ, Wineinger NE, Kang DY, Song J, Garcia S, van Niekerk CJ, Lu CY, Loeks M, Owens RL. Melatonin and Sleep in Preventing Hospitalized Delirium: A Randomized Clinical Trial. Am J Med. 2018 Sep;131(9):1110-1117.e4. doi: 10.1016/j.amjmed.2018.04.009. Epub 2018 May 3.
Results Reference
derived

Learn more about this trial

Melatonin and Sleep in Preventing Delirium in the Hospital

We'll reach out to this number within 24 hrs